BABU GUPTA: Open Payments
NPI 1598763856 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,356 in 113 payments from 17 companies in 2025. Trend: 2023 $1,500 · 2024 $4,563 · 2025 $2,356
Food & beverage: $1,889Travel & lodging: $467
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $569 |
| Otsuka America Pharmaceutical, Inc. | 20 | $304 |
| Noven Therapeutics, LLC | 18 | $229 |
| Alkermes, Inc. | 10 | $193 |
| Vanda Pharmaceuticals Inc. | 8 | $190 |
| Teva Pharmaceuticals USA, Inc. | 8 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $154 |
| Axsome Therapeutics, Inc. | 5 | $115 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
Products named: REXULTI, Xelstrym, ARISTADA, AUSTEDO XR, TRINTELLIX, Auvelity, COBENFY, HETLIOZ.
Industry payments across OH — which companies pay providers there.
